Why “Operation Warp Speed” Could Be Deadly
Opinion | Politicians are dreaming of a “Manhattan Project-style effort” to develop and distribute a coronavirus vaccine “for most Americans by year’s end.” To accomplish this dramatic cut in vaccine development time, “the program will pull together private pharmaceutical companies, government agencies and the military.” Normal vaccine development time is significantly longer. Fourteen potential coronavirus vaccines are vying to […]
Marked Decrease in Hospital Admissions During COVID Pandemic
A curious thing is happening amid the COVID-19 pandemic: As COVID-19 cases and deaths mount, hospital admissions for other acute ailments are markedly dropping. In an Apr. 6, 2020, New York Times article, Dr. Harlan Krumholz—professor of medicine at Yale and director of the Yale New Haven Hospital Center for Outcomes Research and Evaluation—notes:1 The […]
Health Officials Launch Mobile App to Pre-Register Chicagoans for COVID-19 Vaccine
Story Highlights The Chicago Department of Public Health has launched a website and a mobile device application encouraging residents to pre-register to get for a future COVID-19 vaccine. Chicago’s Mayor said the electronic database will be used to prepare plans for mass vaccination of all residents after a COVID-19 vaccine is licensed by the FDA […]
New York on PAUSE During COVID-19 Outbreak
New York has been struggling with responding to one of the worst COVD-19 outbreaks in the world. As of Apr. 25, 2020, an estimated 271,600 people in New York State and 141,754 in New York City have been infected with COVID-19.1 In response to this health crisis, New York Governor Andrew Cuomo has issued an […]
Immunity Booster | Real Time with Bill Maher
I worry that the past two months of quarantine have given people the idea that the way for humans to win our million-year war with microbes is to avoid them completely. And I’m here to tell you… you can’t. The key to beating COVID isn’t dining through glass or never going to a concert or […]
GSK and Sanofi COVID-19 Vaccine Produced in Insect Cells with Squalene Adjuvant
Story Highlights GlaxoSmithKline and Sanofi Pasteur are partnering to develop an experimental COVID-19 vaccine. The two global vaccine manufacturers are using existing recombinant DNA vaccine technology and a squalene adjuvant for their COVID-19 vaccine. Clinical trials are scheduled to begin in the second half of 2020 and, if successful, the vaccine will be available in […]
